FITB
65
2
AAL
16
-13
MSI
47
3
KHC
42
8
A
37
3
SRE
68
2
ED
50
-9
MKC
38
2
GM
57
-6
PNC
59
3
GLW
82
3
NI
75
3
MCK
64
2
VIX
38
-3
TSN
58
2
IRM
47
3
COST
53
2
VTR
63
6
CNX
48
4
EFX
30
3
FITB
65
2
AAL
16
-13
MSI
47
3
KHC
42
8
A
37
3
SRE
68
2
ED
50
-9
MKC
38
2
GM
57
-6
PNC
59
3
GLW
82
3
NI
75
3
MCK
64
2
VIX
38
-3
TSN
58
2
IRM
47
3
COST
53
2
VTR
63
6
CNX
48
4
EFX
30
3
Financhill
Back

Triumph Financial, Inc. Vs. Apogee Therapeutics, Inc. Industry Stock Comparison

Sell
39

TFIN
Triumph Financial, Inc.

Last Price:
$59.97
Seasonality Move:
-3.01%
Sell
44

APGE
Apogee Therapeutics, Inc.

Last Price:
$84.40
Seasonality Move:
-11.77%
Sell
39
Triumph Financial, Inc. (TFIN) is a Sell

Is Triumph Financial, Inc. a Buy, Sell or Hold?

  • The current Triumph Financial, Inc. [TFIN] share price is $59.95. The Score for TFIN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • TFIN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Apogee Therapeutics, Inc. (APGE) is a Sell

Is Apogee Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Apogee Therapeutics, Inc. [APGE] share price is $84.34. The Score for APGE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • APGE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TFIN Stock Price Chart

What is Triumph Financial, Inc.'s stock price today?

  • The Triumph Financial, Inc. share price today is $59.95
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TFIN is experiencing slight buying pressure.

APGE Stock Price Chart

What is Apogee Therapeutics, Inc.'s stock price today?

  • The Apogee Therapeutics, Inc. share price today is $84.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APGE is experiencing buying pressure, which is a positive indicator for future bullish movement.

TFIN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.41 Sell
Relative Strength Index (14 RSI): 54.33 Buy
Chaikin Money Flow: 28039 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (55.98 - 59.56) Buy
Bollinger Bands (100): (55.61 - 66.17) Sell

APGE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.18 Buy
Relative Strength Index (14 RSI): 64.96 Buy
Chaikin Money Flow: 432550 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (69.1 - 79.44) Buy
Bollinger Bands (100): (66.23 - 78.47) Buy

TFIN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 58.2 Buy
20-day SMA: 57.43 Buy
50-day SMA: 61.1 Sell
200-day SMA: 58.96 Buy
8-day EMA: 58.5 Buy
20-day EMA: 58.27 Buy
50-day EMA: 59.75 Buy
200-day EMA: 61.03 Sell

APGE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 79.91 Buy
20-day SMA: 75.21 Buy
50-day SMA: 71.36 Buy
200-day SMA: 57.28 Buy
8-day EMA: 80.37 Buy
20-day EMA: 76.41 Buy
50-day EMA: 73.33 Buy
200-day EMA: 61.58 Buy

Triumph Financial, Inc. Earnings Growth & TFIN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.95 per share, and an increase next year of $1.01 per share.

Apogee Therapeutics, Inc. Earnings Growth & APGE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.62 per share.

Triumph Financial, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apogee Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):